Preemies on steroids: A new iatrogenic disaster?

Birth

Volumn 28, Issue 1, 2001, Pages 57-59

  Harrison, Helen ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

ADULT; ARTICLE; BRAIN; DRUG EFFECT; FEMALE; GROWTH, DEVELOPMENT AND AGING; HUMAN; IATROGENIC DISEASE; INFORMED CONSENT; METHODOLOGY; NEWBORN; PERINATAL CARE; PREMATURITY; RISK ASSESSMENT; TREATMENT OUTCOME;

ADULT; BRAIN; FEMALE; HUMANS; IATROGENIC DISEASE; INFANT, NEWBORN; INFANT, PREMATURE; INFORMED CONSENT; PERINATAL CARE; RISK ASSESSMENT; STEROIDS; TREATMENT OUTCOME;

EID: 0035289687     PISSN: 07307659     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-536x.2001.00057.x     Document Type: Short Survey

References (43)

1. Schmidt B. Prevention of IVH and BPD: International Randomized Placebo-Controlled Trial of Indomethacin Prophylaxis in Preterm Infants (TIPP). Presented at Hot Topics in Neonatology Conference, Washington, DC, Dec 5, 2000.
2. Vohr BR, Wright LL, Dusick AM, et al. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994. Pediatrics 2000;105:1216-1226.
3. Wood NS, Marlow N, Costeloe K, et al. Neurologic and developmental disability after extremely preterm birth. N Engl J Med 2000;343:378-384.
4. McGrath MM, Sullivan MC, Lester BM, Oh W. Longitudinal neurological follow-up in neonatal intensive care unit survivors with various neonatal morbidities. Pediatrics 2000;106: 1397-1405.
5. Peterson BS, Vohr B, Staib, LH, et al. Regional brain volume abnormalities and long-term cognitive outcome in preterm infants. JAMA 2000;284:1939-1947.
6. Hack M, Taylor HG. Perinatal brain injury in preterm infants and later neurobehavioral function. JAMA 2000;284:1973-1974.
7. Eriksson J, Forsen T, Tuomilehto J, et al. Fetal and childhood growth and hypertension in adult life. Hypertension 2000;36 (5):790-794.
8. Jobe A. Overview for prevention of IVH - Why are <1 kg infants normal? Presented at Hot Topics in Neonatology Conference, Washington, DC, Dec 5, 2000.
9. Harrison H. The principles for family-centered neonatal care. Pediatrics 1993;92:643-650.
10. Finer NN, Craft A, Vaucher YE, et al. Postnatal steroids: Short-term gain, long-term pain? J Pediatr 2000;137:9-13.
11. Lorenz JM. Survival of the extremely preterm infant in North America in the 1990s. Clin Perinatol 2000;27:255-262.
12. Halliday HL. Clinical trials of postnatal corticosteroids: Inhaled and systemic. Biol Neonate 1999;76:29-40.
13. Vermont Oxford Network 1998 Database Summary. Burlington, Vermont: Vermont Oxford Network, 1999.
14. Murphy BP, Inder TE, Huppi PS, et al. Quantitative brain growth following treatment with dexamethasone for neonatal chronic lung disease [abstract]. Pediatr Res 2000;47:419A.
15. Shinwell ES, Karplus M, Reich D, et al. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed 2000;83:F177-F181.
16. Yeh TF, Yin YJ, Huang CC, et al. Early dexamethasone therapy in preterm infants: A follow-up study. Pediatrics 1998; 101:E71-E78.
17. O'Shea T, Kothadia J, Klinepeter K, et al. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: Outcome of study participants at I-year adjusted age. Pediatrics 1999;104:15-21.
18. Vohr BR, Phelps D, Wright LL, et al. Effects of neonatal interventions on retinopathy of prematurity (ROP) in extremely low birth weight (ELBW) survivors <1000 grams [abstract]. Pediatr Res 2000;47:327A
19. Halliday HL, Ehrenkranz RA. Delayed (>3weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev 2000:CD001145.
20. Stark AR, Carlo W, Bauer C, et al. Complications of early steroid therapy in a randomized controlled trial [abstract]. Pediatrics Suppl 1999;104:739A.
21. Soll RF, Vermont Oxford Network Steroid Study Group. Early postnatal dexamethasone therapy for the prevention of chronic lung disease [abstract]. Pediatr Res 1999;45:226A.
22. Ortiz LA, Quan A, Weinberg A, et al. Prenatal dexamethasone causes reduced glomerular number and hypertension in adult rats [abstract]. Pediatr Res 200;47:450A.
23. Doyle LW. Antenatal corticosteroid therapy and blood pressure at 14 years of age in preterm children. Clin Sci 2000; 98:137-142.
24. Bakker JM, Kavelaars A, Kampuis PJ, et al. Neonatal dexamethasone treatment increases susceptibility to experimental autoimmune disease in adults. J Immunol 2000;165:5932-5937.
25. Kamisuka MD, Williams MA, Nyberg DA, et al. Renal calicification: A complication of dexamethasone therapy in preterm infants with bronchopulmonary dysplasia. J Perinatol 1995; 15:359-363.
26. Banks BA, Merrill JD, Cnaan A, et al. Multiple courses of antenatal corticosteroids (ANCS): Association with increased mortality and early severe lung disease (ESLD) in preterm neonates [abstract]. Part 3. Pediatrics 1999;104 (3):739.
27. Kamphuis PJGH, Coiset G, Bakker JM, et al. Neonatal treatment with dexamethasone selectively reduces pituitary-adrenal responsiveness of rats to novelty stress in adulthood [abstract]. Pediatr Res 2000;47:71A.
28. Benesova O, Pavlik A. Perinatal treatment with glucocorticoids and the risk of maldevelopment of the brain. Neuropharmacology 1989;28:89-97.
29. National Institute of Health. Antenatal Corticosteroids Revisited: Repeat Courses. NIH Consensus Statement 2000, Bethesda, MD, Aug 17-18;17:1-10.
30. French NP, Hagan R, Evans SF, et al. Repeated antenatal corticosteroids: Size at birth and subsequent development. Am J Obstet Gynecol 1999;180:114-121.
31. French NP, Hagan R, Evans S, et al. Repeated antenatal corticosteroids (CS): Behavior outcomes in a regional population of very preterm (VP, <33w) infants. [abstract]. Pediatr Res 1998:43:214A.
32. Kay HH, Bird IM, Coe CL, et al. Antenatal steroid treatment and adverse fetal effects: What is the evidence? J Soc Gynecol Investig 2000;7:269-278.
33. Bhandari V, Brodsky NL. Repetitive doses of antenatal steroids (ANS) are associated with increased gastroesophageal reflux (GER) [abstract]. Pediatr Res 1999;45:186A.
34. del Moral T, Claure S, VanBuskirk S, et al. Antenatal steroids and incidence of ROP in ELBW infants [abstract]. Pediatr Res 2000;47:395A.
35. Taeusch HW. Glucocorticoid prophylaxis for respiratory distress syndrome: A review of potential toxicity. J Pediatr 1975: 87:617-623.
36. Weichsel ME. The therapeutic use of glucocorticoid hormones in the neonatal period: Potential neurological hazards. Ann Neurol 1977;2:364-366.
37. Frank L. The use of dexamethasone in premature infants at risk for bronchopulmonary dysplasia or who already have developed chronic lung disease: A cautionary note [letter]. Pediatrics 1991;88:413-414.
38. Jobe A. Glucocorticoids in perinatal care: Misguided rockets? J Pediatr 2000;137:1-3.
39. Silverman WA. Where's the Evidence? Debates in Modern Medicine. New York: Oxford University Press, 1998.
40. Silverman WA. Retrolental Fibroplasia: A Modern Parable. New York: Grune & Stratton, 1980.
41. Stahlman MT. Ethical issues in the nursery: Priorities versus limits. J Pediatr 1990;116:167-170.
42. Taylor RS. Postnatal steroid use among neonatologists: Survey results. Dec 2000. http://www.cheo.on.ca/rtaylor/PNSteroid-r.htm
43. Maisels J. as quoted by S J Brown. Neonatal intensive care: Life at what cost? Pediatr News 1993;Jan:1,26.